{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:13:30Z","timestamp":1791562410736,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Vaccine Research Institute","award":["ANR\u201010\u2010LABX\u201077"],"award-info":[{"award-number":["ANR\u201010\u2010LABX\u201077"]}]},{"name":"Labex IBEID","award":["ANR\u201010\u2010LABX62\u2010IBEID"],"award-info":[{"award-number":["ANR\u201010\u2010LABX62\u2010IBEID"]}]},{"name":"ANR\/FRM Flash Covid PROTEO\u2010SARS\u2010CoV\u20102"},{"name":"IDISCOVR"},{"name":"Region Ile\u2010de\u2010France program DIM1\u2010Health"},{"name":"Pasteur\u2010Paris University (PPU) International Doctoral Program"},{"name":"French Ministry of Higher Education, Research and Innovation"},{"name":"Medecine\u2010Sciences ENS\u2010PSL Program"},{"name":"Milieu Int\u00e9rieur Program","award":["ANR\u201010\u2010LABX\u201069\u2010 01"],"award-info":[{"award-number":["ANR\u201010\u2010LABX\u201069\u2010 01"]}]},{"name":"REACTing"},{"name":"EU"},{"name":"The Vaccine Research Institute"},{"name":"Institut Pasteur Department of Virology \"Bourse de Soudure\" fellowship"},{"name":"ANR CoronaMito AAP RA\u2010COVID\u201019 V14"},{"name":"Institut Pasteur"},{"name":"Urgence COVID\u201019 Fundraising Campaign of Institut Pasteur"},{"DOI":"10.13039\/501100002915","name":"Fondation Pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UPBI","award":["ANR\u201010\u2010INSB\u201004\u201001"],"award-info":[{"award-number":["ANR\u201010\u2010INSB\u201004\u201001"]}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00106077"],"award-info":[{"award-number":["00106077"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"published-print":{"date-parts":[[2021,12,15]]},"DOI":"10.15252\/embj.2021108944","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T08:03:23Z","timestamp":1633334603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":199,"title":["SARS\u2010CoV\u20102 Alpha, Beta, and Delta variants display enhanced Spike\u2010mediated syncytia formation"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-8850","authenticated-orcid":false,"given":"Maaran Michael","family":"Rajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0872-1529","authenticated-orcid":false,"given":"Nell","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Robinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Grzelak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Planas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-1378","authenticated-orcid":false,"given":"J\u00e9r\u00e9my","family":"Dufloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1896-7212","authenticated-orcid":false,"given":"Stacy","family":"Gellenoncourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Zivaljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Planchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Guivel\u2010Benhassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Porrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4230-610X","authenticated-orcid":false,"given":"Hugo","family":"Mouquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-3630","authenticated-orcid":false,"given":"Lisa A","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4790-7577","authenticated-orcid":false,"given":"Julian","family":"Buchrieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-1475","authenticated-orcid":false,"given":"Olivier","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"BFEMBJ2021108944_CR1","doi-asserted-by":"crossref","first-page":"100086","DOI":"10.1016\/j.medidd.2021.100086","volume":"10","author":"F Ali","year":"2021","unstructured":"Ali F, Kasry A, Amin M (2021) The new SARS\u2010CoV\u20102 strain shows a stronger binding affinity to ACE2 due to N501Y mutant. Med Drug Discov 10: 100086","journal-title":"Med Drug Discov"},{"key":"BFEMBJ2021108944_CR2","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam PS, Wimmers F, Mok CKP, Perera RAPM, Scott M, Hagan T, Sigal N, Feng Y, Bristow L, Tak\u2010Yin Tsang O et\u00a0al (2020) Systems biological assessment of immunity to mild versus severe COVID\u201019 infection in humans. Science 369: 1210\u20131220","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR3","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.cell.2021.04.033","volume":"184","author":"D Asarnow","year":"2021","unstructured":"Asarnow D, Wang B, Lee W\u2010H, Hu Y, Huang C\u2010W, Faust B, Ng PML, Ngoh EZX, Bohn M, Bulkley D et\u00a0al (2021) Structural insight into SARS\u2010CoV\u20102 neutralizing antibodies and modulation of syncytia. Cell 184: 3192\u20133204.e16","journal-title":"Cell"},{"key":"BFEMBJ2021108944_CR4","doi-asserted-by":"crossref","first-page":"100902","DOI":"10.1016\/j.jbc.2021.100902","volume":"297","author":"CT Barrett","year":"2021","unstructured":"Barrett CT, Neal HE, Edmonds K, Moncman CL, Thompson R, Branttie JM, Boggs KB, Wu CY, Leung DW, Dutch RE (2021) Effect of clinical isolate or cleavage site mutations in the SARS\u2010CoV\u20102 spike protein on protein stability, cleavage, and cell\u2010cell fusion. J Biol Chem 297: 100902","journal-title":"J Biol Chem"},{"key":"BFEMBJ2021108944_CR5","doi-asserted-by":"crossref","first-page":"e20210554","DOI":"10.1084\/jem.20210554","volume":"218","author":"P Bastard","year":"2021","unstructured":"Bastard P, Orlova E, Sozaeva L, Levy R, James A, Schmitt MM, Ochoa S, Kareva M, Rodina Y, Gervais A et\u00a0al (2021) Preexisting autoantibodies to type I IFNs underlie critical COVID\u201019 pneumonia in patients with APS\u20101. J Exp Med 218: e20210554","journal-title":"J Exp Med"},{"key":"BFEMBJ2021108944_CR6","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Beziat V et\u00a0al (2020) Autoantibodies against type I IFNs in patients with life\u2010threatening COVID\u201019. Science 370: eabd4585","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR7","doi-asserted-by":"crossref","unstructured":"Beucher G, Blondot M\u2010L, Celle A, Pied N, Recordon\u2010Pinson P, Esteves P, Faure M, M\u00e9tifiot M, Lacomme S & Dacheaux D et\u00a0al (2021) SARS\u2010CoV\u20102 transmission via apical syncytia release from primary bronchial epithelia and infectivity restriction in children epithelia. bioRxiv 2021.2005.2028.446159 [PREPRINT]","DOI":"10.1101\/2021.05.28.446159"},{"key":"BFEMBJ2021108944_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","volume":"594","author":"L Braga","year":"2021","unstructured":"Braga L, Ali H, Secco I, Chiavacci E, Neves G, Goldhill D, Penn R, Jimenez\u2010Guarde\u00f1o JM, Ortega\u2010Prieto AM, Bussani R et\u00a0al (2021) Drugs that inhibit TMEM16 proteins block SARS\u2010CoV\u20102 spike\u2010induced syncytia. Nature 594: 88\u201393","journal-title":"Nature"},{"key":"BFEMBJ2021108944_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1126\/science.aaw7733","volume":"365","author":"J Buchrieser","year":"2019","unstructured":"Buchrieser J, Degrelle SA, Couderc T, Nevers Q, Disson O, Manet C, Donahue DA, Porrot F, Hillion KH, Perthame E et\u00a0al (2019) IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. Science 365: 176\u2013180","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR10","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106267","volume":"39","author":"J Buchrieser","year":"2020","unstructured":"Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel\u2010Benhassine F, Van der Werf S et\u00a0al (2020) Syncytia formation by SARS\u2010CoV\u20102\u2010infected cells. EMBO J 39: e106267","journal-title":"EMBO J"},{"key":"BFEMBJ2021108944_CR11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.abe9728","volume":"371","author":"LF Buss","year":"2021","unstructured":"Buss LF, Prete CA, Abrahim CMM, Mendrone A, Salomon T, de Almeida\u2010Neto C, Fran\u00e7a RFO, Belotti MC, Carvalho MPSS, Costa AG et\u00a0al (2021) Three\u2010quarters attack rate of SARS\u2010CoV\u20102 in the Brazilian Amazon during a largely unmitigated epidemic. Science 371: 288\u2013292","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR12","doi-asserted-by":"crossref","first-page":"103104","DOI":"10.1016\/j.ebiom.2020.103104","volume":"61","author":"R Bussani","year":"2020","unstructured":"Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L, Volpe MC, Colliva A, Zanconati F, Berlot G et\u00a0al (2020) Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID\u201019 pathology. EBioMedicine 61: 103104","journal-title":"EBioMedicine"},{"key":"BFEMBJ2021108944_CR13","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1038\/s41467-021-25589-1","volume":"12","author":"J Cattin\u2010Ortol\u00e1","year":"2021","unstructured":"Cattin\u2010Ortol\u00e1 J, Welch L, Maslen SL, Skehel JM, Papa G, James LC, Munro S, Cattin\u2010Ortol\u00e1 J, Welch LG, Maslen SL et\u00a0al (2021) Sequences in the cytoplasmic tail of SARS\u2010CoV\u20102 Spike facilitate expression at the cell surface and syncytia formation. Nat Commun 12: 5333","journal-title":"Nat Commun"},{"key":"BFEMBJ2021108944_CR14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jit123","volume":"207","author":"J\u2010W Chan","year":"2013","unstructured":"Chan J\u2010W, Chan K\u2010H, Choi G\u2010Y, To K\u2010W, Tse H, Cai J\u2010P, Yeung ML, Cheng V\u2010C, Chen H, Che X\u2010Y et\u00a0al (2013) Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC\/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 207: 1743\u20131752","journal-title":"J Infect Dis"},{"key":"BFEMBJ2021108944_CR15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, Zhang Z, Fan P, Dong Y, Yang Y et\u00a0al (2020) A neutralizing human antibody binds to the N\u2010terminal domain of the Spike protein of SARS\u2010CoV\u20102. Science 369: 650\u2013655","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","volume":"593","author":"DA Collier","year":"2021","unstructured":"Collier DA, De Marco A, Ferreira IATM, Meng BO, Datir RP, Walls AC, Kemp SA, Bassi J, Pinto D, Silacci\u2010Fregni C et\u00a0al (2021) Sensitivity of SARS\u2010CoV\u20102 B.1.1.7 to mRNA vaccine\u2010elicited antibodies. Nature 593: 136\u2013141","journal-title":"Nature"},{"key":"BFEMBJ2021108944_CR17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2014.11.001","volume":"16","author":"AA Compton","year":"2014","unstructured":"Compton AA, Bruel T, Porrot F, Mallet A, Sachse M, Euvrard M, Liang C, Casartelli N, Schwartz O (2014) IFITM proteins incorporated into HIV\u20101 virions impair viral fusion and spread. Cell Host Microbe 16: 736\u2013747","journal-title":"Cell Host Microbe"},{"key":"BFEMBJ2021108944_CR18","doi-asserted-by":"crossref","first-page":"eabg3055","DOI":"10.1126\/science.abg3055","volume":"372","author":"NG Davies","year":"2021","unstructured":"Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CAB, Russell TW, Tully DC, Washburne AD et\u00a0al (2021) Estimated transmissibility and impact of SARS\u2010CoV\u20102 lineage B.1.1.7 in England. Science 372: eabg3055","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR19","doi-asserted-by":"crossref","first-page":"108959","DOI":"10.1016\/j.celrep.2021.108959","volume":"35","author":"M Dittmar","year":"2021","unstructured":"Dittmar M, Lee JS, Whig K, Segrist E, Li M, Kamalia B, Castellana L, Ayyanathan K, Cardenas\u2010Diaz FL, Morrisey EE et\u00a0al (2021) Drug repurposing screens reveal cell\u2010type\u2010specific entry pathways and FDA\u2010approved drugs active against SARS\u2010Cov\u20102. Cell Rep 35: 108959","journal-title":"Cell Rep"},{"key":"BFEMBJ2021108944_CR20","volume":"8","author":"SR Dominguez","year":"2013","unstructured":"Dominguez SR, Travanty EA, Qian Z, Mason RJ (2013) Human coronavirus HKU1 infection of primary human type II alveolar epithelial cells: cytopathic effects and innate immune response. PLoS One 8: e70129","journal-title":"PLoS One"},{"key":"BFEMBJ2021108944_CR21","doi-asserted-by":"crossref","first-page":"576622","DOI":"10.3389\/fimmu.2020.576622","volume":"11","author":"L Duan","year":"2020","unstructured":"Duan L, Zheng Q, Zhang H, Niu Y, Lou Y, Wang H (2020) The SARS\u2010CoV\u20102 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike\u2010based vaccine immunogens. Front Immunol 11: 576622","journal-title":"Front Immunol"},{"key":"BFEMBJ2021108944_CR22","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1534\/g3.118.200144","volume":"8","author":"S Edie","year":"2018","unstructured":"Edie S, Zaghloul NA, Leitch CC, Klinedinst DK, Lebron J, Thole JF, McCallion AS, Katsanis N, Reeves RH (2018) Survey of human chromosome 21 gene expression effects on early development in Danio Rerio. G3 8: 2215\u20132223","journal-title":"G3"},{"key":"BFEMBJ2021108944_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.08.443253","author":"I Ferreira","year":"2021","unstructured":"Ferreira I, Datir R, Papa G, Kemp S, Meng B, Rakshit P, Singh S, Pandey R, Ponnusamy K, Radhakrishnan VS et\u00a0al (2021) SARS\u2010CoV\u20102 B.1.617 emergence and sensitivity to vaccine\u2010elicited antibodies. bioRxiv https:\/\/doi.org\/10.1101\/2021.05.08.443253 [PREPRINT]","journal-title":"bioRxiv"},{"key":"BFEMBJ2021108944_CR24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S1473-3099(21)00170-5","volume":"21","author":"D Frampton","year":"2021","unstructured":"Frampton D, Rampling T, Cross A, Bailey H, Heaney J, Byott M, Scott R, Sconza R, Price J, Margaritis M et\u00a0al (2021) Genomic characteristics and clinical effect of the emergent SARS\u2010CoV\u20102 B.1.1.7 lineage in London, UK: a whole\u2010genome sequencing and hospital\u2010based cohort study. Lancet Infect Dis 21: 1246\u20131256","journal-title":"Lancet Infect Dis"},{"key":"BFEMBJ2021108944_CR25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0046-8177(03)00367-8","volume":"34","author":"TJ Franks","year":"2003","unstructured":"Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, Selbs E, Mcevoy CPL, Hayden CDL, Fukuoka J et\u00a0al (2003) Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 34: 743\u2013748","journal-title":"Hum Pathol"},{"key":"BFEMBJ2021108944_CR26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Pere H, Charbit B, Bondet V, Chenevier\u2010Gobeaux C et\u00a0al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID\u201019 patients. Science 369: 718\u2013724","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR27","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","volume":"184","author":"M Hoffmann","year":"2021","unstructured":"Hoffmann M, Arora P, Gross R, Seidel A, Hornich BF, Hahn AS, Kruger N, Graichen L, Hofmann\u2010Winkler H, Kempf A et\u00a0al (2021) SARS\u2010CoV\u20102 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell 184: 2384\u20132393 e2312","journal-title":"Cell"},{"key":"BFEMBJ2021108944_CR28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine\u2010Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N\u2010H, Nitsche A et\u00a0al (2020) SARS\u2010CoV\u20102 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181: 271\u2013280.e8","journal-title":"Cell"},{"key":"BFEMBJ2021108944_CR29","doi-asserted-by":"crossref","first-page":"e00002\u201021","DOI":"10.1128\/JVI.00002-21","volume":"95","author":"BF Hornich","year":"2021","unstructured":"Hornich BF, Grosskopf AK, Schlagowski S, Tenbusch M, Kleine\u2010Weber H, Neipel F, Stahl\u2010Hennig C, Hahn AS (2021) SARS\u2010CoV\u20102 and SARS\u2010CoV spike\u2010mediated cell\u2010cell fusion differ in their requirements for receptor expression and proteolytic activation. J Virol 95: e00002\u201021","journal-title":"J Virol"},{"key":"BFEMBJ2021108944_CR30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.abe8499","volume":"370","author":"YJ Hou","year":"2020","unstructured":"Hou YJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH, Leist SR, Sch\u00e4fer A, Nakajima N, Takahashi K et\u00a0al (2020) SARS\u2010CoV\u20102 D614G variant exhibits efficient replication ex\u00a0vivo and transmission in\u00a0vivo. Science 370: 1464\u20131468","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu YI, Zhang LI, Fan G, Xu J, Gu X et\u00a0al (2020a) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497\u2013506","journal-title":"Lancet"},{"key":"BFEMBJ2021108944_CR32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y, Yang C, Xu XF, Xu W, Liu SW (2020b) Structural and functional properties of SARS\u2010CoV\u20102 spike protein: potential antivirus drug development for COVID\u201019. Acta Pharmacol Sin 41: 1141\u20131149","journal-title":"Acta Pharmacol Sin"},{"key":"BFEMBJ2021108944_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.01.446516","author":"L Jackson","year":"2021","unstructured":"Jackson L, Rodel H, Hwa S\u2010H, Cele S, Ganga Y, Tegally H, Bernstein M, Giandhari J, Gosnell BI, Khan K et\u00a0al (2021) SARS\u2010CoV\u20102 cell\u2010to\u2010cell spread occurs rapidly and is insensitive to antibody neutralization. bioRxiv https:\/\/doi.org\/10.1101\/2021.06.01.446516 [PREPRINT]","journal-title":"bioRxiv"},{"key":"BFEMBJ2021108944_CR34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-020-00392-4","volume":"5","author":"X Jiang","year":"2020","unstructured":"Jiang X, Zhang Z, Wang C, Ren H, Gao L, Peng H, Niu Z, Ren H, Huang H, Sun Q (2020) Bimodular effects of D614G mutation on the spike glycoprotein of SARS\u2010CoV\u20102 enhance protein processing, membrane fusion, and viral infectivity. Signal Transduct Target Ther 5: 268","journal-title":"Signal Transduct Target Ther"},{"key":"BFEMBJ2021108944_CR36","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41467-020-19619-7","volume":"11","author":"S Klein","year":"2020","unstructured":"Klein S, Cortese M, Winter SL, Wachsmuth\u2010Melm M, Neufeldt CJ, Cerikan B, Stanifer ML, Boulant S, Bartenschlager R, Chlanda P (2020) SARS\u2010CoV\u20102 structure and replication characterized by in\u00a0situ cryo\u2010electron tomography. Nat Commun 11: 5885","journal-title":"Nat Commun"},{"key":"BFEMBJ2021108944_CR37","volume":"40","author":"J Koch","year":"2021","unstructured":"Koch J, Uckeley ZM, Doldan P, Stanifer M, Boulant S, Lozach PY (2021) TMPRSS2 expression dictates the entry route used by SARS\u2010CoV\u20102 to infect host cells. EMBO J 40: e107821","journal-title":"EMBO J"},{"key":"BFEMBJ2021108944_CR38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2015.06.015","volume":"336","author":"M Kodaka","year":"2015","unstructured":"Kodaka M, Yang Z, Nakagawa K, Maruyama J, Xu X, Sarkar A, Ichimura A, Nasu Y, Ozawa T, Iwasa H et\u00a0al (2015) A new cell\u2010based assay to evaluate myogenesis in mouse myoblast C2C12 cells. Exp Cell Res 336: 171\u2013181","journal-title":"Exp Cell Res"},{"key":"BFEMBJ2021108944_CR39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B et\u00a0al (2020) Tracking changes in SARS\u2010CoV\u20102 spike: evidence that D614G increases infectivity of the COVID\u201019 virus. Cell 182: 812\u2013827.e19","journal-title":"Cell"},{"key":"BFEMBJ2021108944_CR40","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1128\/jvi.71.4.3285-3287.1997","volume":"71","author":"C Krempl","year":"1997","unstructured":"Krempl C, Schultze B, Laude H, Herrler G (1997) Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol 71: 3285\u20133287","journal-title":"J Virol"},{"key":"BFEMBJ2021108944_CR41","doi-asserted-by":"crossref","unstructured":"Leung K, Shum MH, Leung GM, Lam TT, Wu JT (2021) Early transmissibility assessment of the N501Y mutant strains of SARS\u2010CoV\u20102 in the United Kingdom, October to November 2020. Euro Surveill 26","DOI":"10.2807\/1560-7917.ES.2020.26.1.2002106"},{"key":"BFEMBJ2021108944_CR42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC et\u00a0al (2003) Angiotensin\u2010converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450\u2013454","journal-title":"Nature"},{"key":"BFEMBJ2021108944_CR43","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41418-021-00795-y","volume":"28","author":"L Lin","year":"2021","unstructured":"Lin L, Li Q, Wang Y, Shi Y (2021) Syncytia formation during SARS\u2010CoV\u20102 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differ 28: 2019\u20132021","journal-title":"Cell Death Differ"},{"key":"BFEMBJ2021108944_CR44","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.08.434499","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu J, Plante KS, Plante JA, Xie X, Zhang X, Ku Z, An Z, Scharton D, Schindewolf C et\u00a0al (2021a) The N501Y spike substitution enhances SARS\u2010CoV\u20102 transmission. bioRxiv https:\/\/doi.org\/10.1101\/2021.03.08.434499 [PREPRINT]","journal-title":"bioRxiv"},{"key":"BFEMBJ2021108944_CR46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","volume":"29","author":"Z Liu","year":"2021","unstructured":"Liu Z, VanBlargan LA, Bloyet L\u2010M, Rothlauf PW, Chen RE, Stumpf S, Zhao H, Errico JM, Theel ES, Liebeskind MJ et\u00a0al (2021b) Identification of SARS\u2010CoV\u20102 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe 29: 477\u2013488.e4","journal-title":"Cell Host Microbe"},{"key":"BFEMBJ2021108944_CR47","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/1873-3468.14076","volume":"595","author":"B Luan","year":"2021","unstructured":"Luan B, Wang H, Huynh T (2021) Enhanced binding of the N501Y\u2010mutated SARS\u2010CoV\u20102 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations. FEBS Lett 595: 1454\u20131461","journal-title":"FEBS Lett"},{"key":"BFEMBJ2021108944_CR247","doi-asserted-by":"crossref","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","volume":"35","author":"B Meng","year":"2021","unstructured":"Meng B, Kemp SA, Papa G, Datir R, Ferreira IA, Marelli S, Harvey WT, Lytras S, Mohamed A, Gallo G et\u00a0al (2021) Recurrent emergence of SARS\u2010CoV\u20102 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7. Cell Rep 35: 109292","journal-title":"Cell Rep"},{"key":"BFEMBJ2021108944_CR48","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/vir.0.80671-0","volume":"86","author":"B Nal","year":"2005","unstructured":"Nal B, Chan C, Kien F, Siu L, Tse J, Chu K, Kam J, Staropoli I, Crescenzo\u2010Chaigne B, Escriou N et\u00a0al (2005) Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol 86: 1423\u20131434","journal-title":"J Gen Virol"},{"key":"BFEMBJ2021108944_CR49","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.13.426558","author":"G Nelson","year":"2021","unstructured":"Nelson G, Buzko O, Spilman P, Niazi K, Rabizadeh S, Soon\u2010Shiong P (2021) Molecular dynamic simulation reveals E484K mutation enhances spike RBD\u2010ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant. bioRxiv https:\/\/doi.org\/10.1101\/2021.01.13.426558 [PREPRINT]","journal-title":"bioRxiv"},{"key":"BFEMBJ2021108944_CR50","volume":"17","author":"T Ou","year":"2021","unstructured":"Ou T, Mou H, Zhang L, Ojha A, Choe H, Farzan M (2021) Hydroxychloroquine\u2010mediated inhibition of SARS\u2010CoV\u20102 entry is attenuated by TMPRSS2. PLoS Pathog 17: e1009212","journal-title":"PLoS Pathog"},{"key":"BFEMBJ2021108944_CR51","doi-asserted-by":"crossref","first-page":"100059","DOI":"10.1016\/j.xcrm.2020.100059","volume":"1","author":"A Pizzorno","year":"2020","unstructured":"Pizzorno A, Padey B, Julien T, Trouillet\u2010Assant S, Traversier A, Errazuriz\u2010Cerda E, Fouret J, Dubois J, Gaymard A, Lescure F\u2010X et\u00a0al (2020) Characterization and treatment of SARS\u2010CoV\u20102 in nasal and bronchial human airway epithelia. Cell Rep Med 1: 100059","journal-title":"Cell Rep Med"},{"key":"BFEMBJ2021108944_CR52","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","volume":"27","author":"D Planas","year":"2021","unstructured":"Planas D, Bruel T, Grzelak L, Guivel\u2010Benhassine F, Staropoli I, Porrot F, Planchais C, Buchrieser J, Rajah MM, Bishop E et\u00a0al (2021a) Sensitivity of infectious SARS\u2010CoV\u20102 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med 27: 917\u2013924","journal-title":"Nat Med"},{"key":"BFEMBJ2021108944_CR53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","volume":"596","author":"D Planas","year":"2021","unstructured":"Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel\u2010Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J et\u00a0al (2021b) Reduced sensitivity of SARS\u2010CoV\u20102 variant Delta to antibody neutralization. Nature 596: 276\u2013280","journal-title":"Nature"},{"key":"BFEMBJ2021108944_CR54","doi-asserted-by":"crossref","first-page":"109364","DOI":"10.1016\/j.celrep.2021.109364","volume":"36","author":"M Puray\u2010Chavez","year":"2021","unstructured":"Puray\u2010Chavez M, LaPak KM, Schrank TP, Elliott JL, Bhatt DP, Agajanian MJ, Jasuja R, Lawson DQ, Davis K, Rothlauf PW et\u00a0al (2021) Systematic analysis of SARS\u2010CoV\u20102 infection of an ACE2\u2010negative human airway cell. Cell Rep 36: 109364","journal-title":"Cell Rep"},{"key":"BFEMBJ2021108944_CR55","volume":"8","author":"Z Qian","year":"2013","unstructured":"Qian Z, Dominguez SR, Holmes KV (2013) Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS\u2010CoV) in virus entry and syncytia formation. PLoS One 8: e76469","journal-title":"PLoS One"},{"key":"BFEMBJ2021108944_CR56","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1473-3099(21)00262-0","volume":"21","author":"M Ramanathan","year":"2021","unstructured":"Ramanathan M, Ferguson ID, Miao W, Khavari PA (2021) SARS\u2010CoV\u20102 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. Lancet Infect Dis 21: 1070","journal-title":"Lancet Infect Dis"},{"key":"BFEMBJ2021108944_CR57","doi-asserted-by":"crossref","first-page":"108890","DOI":"10.1016\/j.celrep.2021.108890","volume":"34","author":"C Rees\u2010Spear","year":"2021","unstructured":"Rees\u2010Spear C, Muir L, Griffith SA, Heaney J, Aldon Y, Snitselaar JL, Thomas P, Graham C, Seow J, Lee N et\u00a0al (2021) The effect of spike mutations on SARS\u2010CoV\u20102 neutralization. Cell Rep 34: 108890","journal-title":"Cell Rep"},{"key":"BFEMBJ2021108944_CR59","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1038\/s41467-021-24521-x","volume":"12","author":"R Robinot","year":"2021","unstructured":"Robinot R, Hubert M, de Melo GD, Lazarini F, Bruel T, Smith N, Levallois S, Larrous F, Fernandes J, Gellenoncourt S et\u00a0al (2021) SARS\u2010CoV\u20102 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat Commun 12: 4354","journal-title":"Nat Commun"},{"key":"BFEMBJ2021108944_CR60","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(21)00183-5","volume":"397","author":"EC Sabino","year":"2021","unstructured":"Sabino EC, Buss LF, Carvalho MPS, Prete CA, Crispim MAE, Fraiji NA, Pereira RHM, Parag KV, da Silva Peixoto P, Kraemer MUG et\u00a0al (2021) Resurgence of COVID\u201019 in Manaus, Brazil, despite high seroprevalence. Lancet 397: 452\u2013455","journal-title":"Lancet"},{"key":"BFEMBJ2021108944_CR61","doi-asserted-by":"crossref","first-page":"e65962","DOI":"10.7554\/eLife.65962","volume":"10","author":"DW Sanders","year":"2021","unstructured":"Sanders DW, Jumper CC, Ackerman PJ, Bracha D, Donlic A, Kim H, Kenney D, Castello\u2010Serrano I, Suzuki S, Tamura T et\u00a0al (2021) SARS\u2010CoV\u20102 requires cholesterol for viral entry and pathological syncytia formation. Elife 10: e65962","journal-title":"Elife"},{"key":"BFEMBJ2021108944_CR62","volume":"40","author":"G Shi","year":"2021","unstructured":"Shi G, Kenney AD, Kudryashova E, Zani A, Zhang L, Lai KK, Hall\u2010Stoodley L, Robinson RT, Kudryashov DS, Compton AA et\u00a0al (2021) Opposing activities of IFITM proteins in SARS\u2010CoV\u20102 infection. EMBO J 40: e106501","journal-title":"EMBO J"},{"key":"BFEMBJ2021108944_CR63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12977-017-0377-y","volume":"14","author":"G Shi","year":"2017","unstructured":"Shi G, Schwartz O, Compton AA (2017) More than meets the I: the diverse antiviral and cellular functions of interferon\u2010induced transmembrane proteins. Retrovirology 14: 53","journal-title":"Retrovirology"},{"key":"BFEMBJ2021108944_CR64","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD (2021) Prospective mapping of viral mutations that escape antibodies used to treat COVID\u201019. Science 371: 850\u2013854","journal-title":"Science"},{"key":"BFEMBJ2021108944_CR65","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.21.20248640","author":"H Tegally","year":"2020","unstructured":"Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N et\u00a0al (2020) Emergence and rapid spread of a new severe acute respiratory syndrome\u2010related coronavirus 2 (SARS\u2010CoV\u20102) lineage with multiple spike mutations in South Africa. medRxiv https:\/\/doi.org\/10.1101\/2020.12.21.20248640 [PREPRINT]","journal-title":"medRxiv"},{"key":"BFEMBJ2021108944_CR66","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.06.446826","author":"LG Thorne","year":"2021","unstructured":"Thorne LG, Bouhaddou M, Reuschl A\u2010K, Zuliani\u2010Alvarez L, Polacco B, Pelin A, Batra J, Whelan MVX, Ummadi M, Rojc A et\u00a0al (2021) Evolution of enhanced innate immune evasion by the SARS\u2010CoV\u20102 B.1.1.7 UK variant. bioRxiv https:\/\/doi.org\/10.1101\/2021.06.06.446826 [PREPRINT]","journal-title":"bioRxiv"},{"key":"BFEMBJ2021108944_CR67","volume":"10","author":"F Tian","year":"2021","unstructured":"Tian F, Tong B, Sun L, Shi S, Zheng B, Wang Z, Dong X, Zheng P (2021) N501Y mutation of spike protein in SARS\u2010CoV\u20102 strengthens its binding to receptor ACE2. eLife 10: e69091","journal-title":"eLife"},{"key":"BFEMBJ2021108944_CR68","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","volume":"15","author":"S Tian","year":"2020","unstructured":"Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY (2020) Pulmonary pathology of early\u2010phase 2019 novel Coronavirus (COVID\u201019) pneumonia in two patients with lung cancer. J Thorac Oncol 15: 700\u2013704","journal-title":"J Thorac Oncol"},{"key":"BFEMBJ2021108944_CR69","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00850-21","volume":"12","author":"F Touret","year":"2021","unstructured":"Touret F, Luciani L, Baronti C, Cochin M, Driouich J\u2010S, Gilles M, Thirion L, Nougair\u00e8de A, de Lamballerie X (2021) Replicative fitness of a SARS\u2010CoV\u20102 20I\/501Y.V1 variant from lineage B.1.1.7 in human reconstituted bronchial epithelium. mBio 12: e00850\u201021","journal-title":"mBio"},{"key":"BFEMBJ2021108944_CR70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI van der Made","year":"2020","unstructured":"van der Made CI, Simons A, Schuurs\u2010Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, van Deuren RC, Steehouwer M, van Reijmersdal SV, Jaeger M et\u00a0al (2020) Presence of genetic variants among young men with severe COVID\u201019. JAMA 324: 663\u2013673","journal-title":"JAMA"},{"key":"BFEMBJ2021108944_CR71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61312","volume":"9","author":"Y Weisblum","year":"2020","unstructured":"Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JCC, Muecksch F, Rutkowska M, Hoffmann HH et\u00a0al (2020) Escape from neutralizing antibodies by SARS\u2010CoV\u20102 spike protein variants. eLife 9: e61312","journal-title":"eLife"},{"key":"BFEMBJ2021108944_CR72","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu LI et\u00a0al (2020) Pathological findings of COVID\u201019 associated with acute respiratory distress syndrome. Lancet Respir Med 8: 420\u2013422","journal-title":"Lancet Respir Med"},{"key":"BFEMBJ2021108944_CR73","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.23.441101","author":"PD Yadav","year":"2021","unstructured":"Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit DA, Gupta N, Sahay RR, Shete AM et\u00a0al (2021) Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. bioRxiv https:\/\/doi.org\/10.1101\/2021.04.23.441101 [PREPRINT]","journal-title":"bioRxiv"},{"key":"BFEMBJ2021108944_CR74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","volume":"183","author":"L Yurkovetskiy","year":"2020","unstructured":"Yurkovetskiy L, Wang X, Pascal KE, Tomkins\u2010Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C et\u00a0al (2020) Structural and functional analysis of the D614G SARS\u2010CoV\u20102 spike protein variant. Cell 183: 739\u2013751 e738","journal-title":"Cell"},{"key":"BFEMBJ2021108944_CR75","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","volume":"6","author":"J Zahradn\u00edk","year":"2021","unstructured":"Zahradn\u00edk J, Marciano S, Shemesh M, Zoler E, Chiaravalli J, Meyer B, Rudich Y, Dym O, Elad N, Schreiber G et\u00a0al (2021) SARS\u2010CoV\u20102 variant prediction and antiviral drug design are enabled by RBD in\u00a0vitro evolution. Nat Microbiol 6: 1188\u20131198","journal-title":"Nat Microbiol"},{"key":"BFEMBJ2021108944_CR76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40588-018-0103-0","volume":"5","author":"A Zani","year":"2018","unstructured":"Zani A, Yount JS (2018) Antiviral protection by IFITM3 in\u00a0vivo. Curr Clin Microbiol Rep 5: 229\u2013237","journal-title":"Curr Clin Microbiol Rep"},{"key":"BFEMBJ2021108944_CR77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z, Jia X, Wu M, Shi B, Xu S et\u00a0al (2020) Viral and host factors related to the clinical outcome of COVID\u201019. Nature 583: 437\u2013440","journal-title":"Nature"},{"key":"BFEMBJ2021108944_CR78","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/s41418-021-00782-3","volume":"28","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zheng Y, Niu Z, Zhang BO, Wang C, Yao X, Peng H, Franca DN, Wang Y, Zhu Y et\u00a0al (2021) SARS\u2010CoV\u20102 spike protein dictates syncytium\u2010mediated lymphocyte elimination. Cell Death Differ 28: 2765\u20132777","journal-title":"Cell Death Differ"},{"key":"BFEMBJ2021108944_CR79","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1038\/s41467-019-10897-4","volume":"10","author":"H Zhou","year":"2019","unstructured":"Zhou H, Chen Y, Zhang S, Niu P, Qin K, Jia W, Huang B, Zhang S, Lan J, Zhang L et\u00a0al (2019) Structural definition of a neutralization epitope on the N\u2010terminal domain of MERS\u2010CoV spike glycoprotein. Nat Commun 10: 3068","journal-title":"Nat Commun"},{"key":"BFEMBJ2021108944_CR80","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","volume":"27","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Ren L, Zhang LI, Zhong J, Xiao Y, Jia Z, Guo LI, Yang J, Wang C, Jiang S et\u00a0al (2020) Heightened innate immune responses in the respiratory tract of COVID\u201019 patients. Cell Host Microbe 27: 883\u2013890.e2","journal-title":"Cell Host Microbe"},{"key":"BFEMBJ2021108944_CR81","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1038\/s41467-020-17796-z","volume":"11","author":"NA Zhu","year":"2020","unstructured":"Zhu NA, Wang W, Liu Z, Liang C, Wang W, Ye F, Huang B, Zhao LI, Wang H, Zhou W et\u00a0al (2020) Morphogenesis and cytopathic effect of SARS\u2010CoV\u20102 infection in human airway epithelial cells. Nat Commun 11: 3910","journal-title":"Nat Commun"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embj.2021108944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embj.2021108944","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embj.2021108944\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embj.2021108944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embj.2021108944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:20:13Z","timestamp":1779308413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embj.2021108944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":79,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,12,15]]}},"alternative-id":["BFEMBJ2021108944"],"URL":"https:\/\/doi.org\/10.15252\/embj.2021108944","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.11.448011","asserted-by":"object"}]},"ISSN":["0261-4189","1460-2075"],"issn-type":[{"value":"0261-4189","type":"print"},{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CP, HM, and OS have a pending patent application for some of the anti\u2010SARS\u2010CoV\u20102 mAbs described in the present study (PCT\/FR2021\/070522).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"EMBJ2021108944"}}